281 related articles for article (PubMed ID: 15753541)
1. Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial.
Gordon JN; Trebble TM; Ellis RD; Duncan HD; Johns T; Goggin PM
Gut; 2005 Apr; 54(4):540-5. PubMed ID: 15753541
[TBL] [Abstract][Full Text] [Related]
2. Poor tolerability of thalidomide in end-stage oesophageal cancer.
Wilkes EA; Selby AL; Cole AT; Freeman JG; Rennie MJ; Khan ZH
Eur J Cancer Care (Engl); 2011 Sep; 20(5):593-600. PubMed ID: 21521389
[TBL] [Abstract][Full Text] [Related]
3. The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study.
Yennurajalingam S; Willey JS; Palmer JL; Allo J; Del Fabbro E; Cohen EN; Tin S; Reuben JM; Bruera E
J Palliat Med; 2012 Oct; 15(10):1059-64. PubMed ID: 22880820
[TBL] [Abstract][Full Text] [Related]
4. Oesophageal cancer and cachexia: the effect of short-term treatment with thalidomide on weight loss and lean body mass.
Khan ZH; Simpson EJ; Cole AT; Holt M; MacDonald I; Pye D; Austin A; Freeman JG
Aliment Pharmacol Ther; 2003 Mar; 17(5):677-82. PubMed ID: 12641516
[TBL] [Abstract][Full Text] [Related]
5. Clinical studies on the treatment of cancer cachexia with megestrol acetate plus thalidomide.
Wen HS; Li X; Cao YZ; Zhang CC; Yang F; Shi YM; Peng LM
Chemotherapy; 2012; 58(6):461-7. PubMed ID: 23406994
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide and cancer cachexia: old problem, new hope?
Stroud M
Gut; 2005 Apr; 54(4):447-8. PubMed ID: 15753523
[No Abstract] [Full Text] [Related]
7. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.
Garcia JM; Boccia RV; Graham CD; Yan Y; Duus EM; Allen S; Friend J
Lancet Oncol; 2015 Jan; 16(1):108-16. PubMed ID: 25524795
[TBL] [Abstract][Full Text] [Related]
8. Clinical study on thalidomide combined with cinobufagin to treat lung cancer cachexia.
Xie M; Chen X; Qin S; Bao Y; Bu K; Lu Y
J Cancer Res Ther; 2018 Jan; 14(1):226-232. PubMed ID: 29516990
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide in the treatment of cancer cachexia.
Tassinari D; Santelmo C; Tombesi P; Sartori S
J Palliat Care; 2008; 24(3):187-9. PubMed ID: 18942570
[No Abstract] [Full Text] [Related]
10. L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)--a randomized multicentre trial.
Kraft M; Kraft K; Gärtner S; Mayerle J; Simon P; Weber E; Schütte K; Stieler J; Koula-Jenik H; Holzhauer P; Gröber U; Engel G; Müller C; Feng YS; Aghdassi A; Nitsche C; Malfertheiner P; Patrzyk M; Kohlmann T; Lerch MM
Nutr J; 2012 Jul; 11():52. PubMed ID: 22824168
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient-reported outcomes in pancreatic cancer cachexia.
Gresham G; Placencio-Hickok VR; Lauzon M; Nguyen T; Kim H; Mehta S; Paski S; Pandol SJ; Osipov A; Gong J; Jamil LH; Nissen N; Lo SK; Hendifar AE
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1959-1968. PubMed ID: 34609081
[TBL] [Abstract][Full Text] [Related]
12. Exercise for cancer cachexia in adults.
Grande AJ; Silva V; Sawaris Neto L; Teixeira Basmage JP; Peccin MS; Maddocks M
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD010804. PubMed ID: 33735441
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial.
Lee SM; Woll PJ; Rudd R; Ferry D; O'Brien M; Middleton G; Spiro S; James L; Ali K; Jitlal M; Hackshaw A
J Natl Cancer Inst; 2009 Aug; 101(15):1049-57. PubMed ID: 19608997
[TBL] [Abstract][Full Text] [Related]
14. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia.
Fearon KC; Barber MD; Moses AG; Ahmedzai SH; Taylor GS; Tisdale MJ; Murray GD
J Clin Oncol; 2006 Jul; 24(21):3401-7. PubMed ID: 16849754
[TBL] [Abstract][Full Text] [Related]
15. Thalidomide for managing cancer cachexia.
Reid J; Mills M; Cantwell M; Cardwell CR; Murray LJ; Donnelly M
Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD008664. PubMed ID: 22513961
[TBL] [Abstract][Full Text] [Related]
16. Thalidomide Celgene Corp.
Bruyn GA
IDrugs; 1998 Aug; 1(4):490-500. PubMed ID: 18465584
[TBL] [Abstract][Full Text] [Related]
17. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials.
Temel JS; Abernethy AP; Currow DC; Friend J; Duus EM; Yan Y; Fearon KC
Lancet Oncol; 2016 Apr; 17(4):519-531. PubMed ID: 26906526
[TBL] [Abstract][Full Text] [Related]
18. Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia.
Mantovani G
Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):292-301. PubMed ID: 20496538
[TBL] [Abstract][Full Text] [Related]
19. Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study.
Yeh SS; Wu SY; Lee TP; Olson JS; Stevens MR; Dixon T; Porcelli RJ; Schuster MW
J Am Geriatr Soc; 2000 May; 48(5):485-92. PubMed ID: 10811540
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122).
Berk L; James J; Schwartz A; Hug E; Mahadevan A; Samuels M; Kachnic L;
Support Care Cancer; 2008 Oct; 16(10):1179-88. PubMed ID: 18293016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
